Tempus AI Diagnostics Chief Sells Shares Amid Volatile Week
Thomas Edward Schoenherr, CEO of diagnostics at Tempus AI (TEM), sold 17,314 shares on August 18 and 19 under a pre-established Rule 10b5-1 trading plan. The transaction totaled approximately $930,000 based on an average sale price of $53.71 per share. The sales were primarily to cover tax obligations from the vesting of restricted stock units and did not reflect any immediate negative sentiment toward the company’s prospects. Schoenherr still holds 89,715 shares directly, representing a 0.05% stake in Tempus AI, which has a market cap of $10.7 billion but reported a net loss of $254.4 million for its trailing twelve months. The stock had been volatile during the week due to news surrounding Moderna and Merck’s trial results impacting perceptions around Tempus's pending Personalis deal. Schoenherr’s sales occurred across both sides of this price movement, consistent with a pre-set trading plan.
Tickers: $TEM
Topics: executive activity SEC filing stock sale